These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

102 related items for PubMed ID: 22760032

  • 1. Osteocalcin, cortisol levels, and bone mineral density in prepubertal children with asthma treated with long-term fluticasone propionate.
    Ozkaya E, Nursoy MA, Uzuner S, Erenberk U, Çakır E.
    Horm Res Paediatr; 2012; 77(6):351-7. PubMed ID: 22760032
    [Abstract] [Full Text] [Related]

  • 2. Bone mineral density and associated parameters in pre-pubertal children with asthma treated with long-term fluticasone propionate.
    Ozkaya E, Çakır E, Uzuner S, Erenberk U, Dundaröz MR.
    Allergol Immunopathol (Madr); 2013; 41(2):102-7. PubMed ID: 22405466
    [Abstract] [Full Text] [Related]

  • 3. Evaluation impact of long-term usage of inhaled fluticasone propionate on ocular functions in children with asthma.
    Emin O, Fatih M, Mustafa O, Nedim S, Osman C.
    Steroids; 2011 May; 76(6):548-52. PubMed ID: 21335020
    [Abstract] [Full Text] [Related]

  • 4. Potential effects of fluticasone propionate on bone mineral density in patients with asthma: a 2-year randomized, double-blind, placebo-controlled trial.
    Kemp JP, Osur S, Shrewsbury SB, Herje NE, Duke SP, Harding SM, Faulkner K, Crim CC.
    Mayo Clin Proc; 2004 Apr; 79(4):458-66. PubMed ID: 15065610
    [Abstract] [Full Text] [Related]

  • 5. One year prospective open study of the effect of high dose inhaled steroids, fluticasone propionate, and budesonide on bone markers and bone mineral density.
    Hughes JA, Conry BG, Male SM, Eastell R.
    Thorax; 1999 Mar; 54(3):223-9. PubMed ID: 10325897
    [Abstract] [Full Text] [Related]

  • 6. Effect of high-dose fluticasone propionate on bone density and metabolism in children with asthma.
    Griffiths AL, Sim D, Strauss B, Rodda C, Armstrong D, Freezer N.
    Pediatr Pulmonol; 2004 Feb; 37(2):116-21. PubMed ID: 14730656
    [Abstract] [Full Text] [Related]

  • 7. The comparison of the effects of fluticasone propionate and budesonide on clinical indices and on bone mineral density in the asthmatic patients: a one year treatment study.
    Harmanci E, Ak I, Ozdemir N, Vardareli E, Elbek O, Uçgun I.
    Allergol Immunopathol (Madr); 1999 Feb; 27(6):298-303. PubMed ID: 10611554
    [Abstract] [Full Text] [Related]

  • 8. Mineral status of COPD patients under long-term inhaled corticosteroid therapy.
    Buyukkaplan US, Akkaya A, Yildiz M, Bircan A, Aksoy Dogan A, Ozturk O.
    J Prosthodont; 2008 Aug; 17(6):462-7. PubMed ID: 18573148
    [Abstract] [Full Text] [Related]

  • 9. Fluticasone propionate powder and lack of clinically significant effects on hypothalamic-pituitary-adrenal axis and bone mineral density over 2 years in adults with mild asthma.
    Li JT, Ford LB, Chervinsky P, Weisberg SC, Kellerman DJ, Faulkner KG, Herje NE, Hamedani A, Harding SM, Shah T.
    J Allergy Clin Immunol; 1999 Jun; 103(6):1062-8. PubMed ID: 10359887
    [Abstract] [Full Text] [Related]

  • 10. Short-term dose-response relationships for the relative systemic effects of oral prednisolone and inhaled fluticasone in asthmatic adults.
    Wilson AM, Lipworth BJ.
    Br J Clin Pharmacol; 1999 Oct; 48(4):579-85. PubMed ID: 10583029
    [Abstract] [Full Text] [Related]

  • 11. Safety and efficacy of fluticasone and beclomethasone in moderate to severe asthma. Belgian Multicenter Study Group.
    Pauwels RA, Yernault JC, Demedts MG, Geusens P.
    Am J Respir Crit Care Med; 1998 Mar; 157(3 Pt 1):827-32. PubMed ID: 9517598
    [Abstract] [Full Text] [Related]

  • 12. Efficacy and safety of a 12-week therapy with a new formulation of fluticasone propionate at doses of 125 and 250 μg administered through a new generation cyclohaler twice daily, in comparison to fluticasone propionate 500 μg dry powder inhaler twice daily in patients with moderate asthma.
    Kupryś-Lipińska I, Tworek D, Vanderbist F, Bocheńska-Marciniak M, Kuna P.
    Pneumonol Alergol Pol; 2013 Mar; 81(6):527-36. PubMed ID: 24142782
    [Abstract] [Full Text] [Related]

  • 13. Inhaled salmeterol and fluticasone: a study comparing monotherapy and combination therapy in asthma.
    Pearlman DS, Stricker W, Weinstein S, Gross G, Chervinsky P, Woodring A, Prillaman B, Shah T.
    Ann Allergy Asthma Immunol; 1999 Mar; 82(3):257-65. PubMed ID: 10094216
    [Abstract] [Full Text] [Related]

  • 14. Basal cortisol in asthmatics on two different doses of fluticasone propionate.
    Andrade CR, Camargos PA, Ibiapina Cda C, Lasmar LM.
    J Pediatr (Rio J); 2008 Mar; 84(4):373-6. PubMed ID: 18679556
    [Abstract] [Full Text] [Related]

  • 15. Safety of inhaled fluticasone propionate therapy for pediatric asthma - a systematic review.
    Muley P, Shah M, Muley A.
    Curr Drug Saf; 2013 Jul; 8(3):186-94. PubMed ID: 23859431
    [Abstract] [Full Text] [Related]

  • 16. Effects of mometasone, fluticasone, and montelukast on bone mineral density in adults with asthma.
    Maspero J, Backer V, Yao R, Staudinger H, Teper A.
    J Allergy Clin Immunol Pract; 2013 Jul; 1(6):649-55.e1. PubMed ID: 24565713
    [Abstract] [Full Text] [Related]

  • 17. Efficacy and safety profile of fluticasone furoate administered once daily in the morning or evening: a randomized, double-blind, double-dummy, placebo-controlled trial in adult and adolescent patients with persistent bronchial asthma.
    Medley H, Orozco S, Allen A.
    Clin Ther; 2012 Aug; 34(8):1683-95. PubMed ID: 22796247
    [Abstract] [Full Text] [Related]

  • 18. Efficacy and safety of inhaled fluticasone propionate chlorofluorocarbon in 2- to 4-year-old patients with asthma: results of a double-blind, placebo-controlled study.
    Wasserman RL, Baker JW, Kim KT, Blake KV, Scott CA, Wu W, Faris MA, Crim C.
    Ann Allergy Asthma Immunol; 2006 Jun; 96(6):808-18. PubMed ID: 16802768
    [Abstract] [Full Text] [Related]

  • 19. The safety of twice-daily treatment with fluticasone propionate and salmeterol in pediatric patients with persistent asthma.
    Malone R, LaForce C, Nimmagadda S, Schoaf L, House K, Ellsworth A, Dorinsky P.
    Ann Allergy Asthma Immunol; 2005 Jul; 95(1):66-71. PubMed ID: 16095144
    [Abstract] [Full Text] [Related]

  • 20. Diskus and diskhaler: efficacy and safety of fluticasone propionate via two dry powder inhalers in subjects with mild-to-moderate persistent asthma.
    Galant SP, van Bavel J, Finn A, Gross G, Pleskow W, Brown A, Hamedani AG, Harding SM.
    Ann Allergy Asthma Immunol; 1999 Mar; 82(3):273-80. PubMed ID: 10094218
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.